Ray Dalio Johnson & Johnson Transaction History

Bridgewater Associates, LP

$19.6 Billion
Q1 2024

A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Johnson & Johnson stock. As of the latest transaction made, Bridgewater Associates, LP holds 2,843,233 shares of JNJ stock, worth $440 Million. This represents 2.3% of its overall portfolio holdings.

Number of Shares

2,843,233

Previous 2,774,687 2.47%

Holding current value

$440 Million

Previous $435 Million 3.42%

% of portfolio

2.3%

Previous 2.45%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$155.22 - $162.74 $10.6 Million - $11.2 Million	68,546 Added 2.47%	2,843,233 $450 Million
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $7.33 Million - $8 Million	50,332 Added 1.85%	2,774,687 $435 Million
Q3 2023 Nov 13, 2023	SELL	$155.75 - $174.48 $71.2 Million - $79.8 Million	-457,073 Reduced 14.37%	2,724,355 $424 Million
Q2 2023 Aug 11, 2023	SELL	$154.35 - $166.11 $62.7 Million - $67.4 Million	-406,023 Reduced 11.32%	3,181,428 $527 Million
Q1 2023 May 12, 2023	BUY	$151.05 - $180.26 $2.95 Million - $3.53 Million	19,563 Added 0.55%	3,587,451 $556 Million

Q4 2022 Feb 13, 2023	SELL	$160.2 - $179.79 $183 Million - $206 Million	-1,144,625 Reduced 24.29%	3,567,888 $630 Million
Q3 2022 Nov 10, 2022	BUY	$161.33 - $179.52 $61.3 Million - $68.2 Million	379,880 Added 8.77%	4,712,513 $770 Million
Q2 2022 Aug 11, 2022	SELL	$168.19 - $186.01 $2.08 Million - $2.3 Million	-12,369 Reduced 0.28%	4,332,633 $769 Million
Q1 2022 May 13, 2022	BUY	$158.14 - $179.59 $197 Million - $224 Million	1,247,260 Added 40.26%	4,345,002 $770 Million
Q4 2021 Feb 14, 2022	BUY	$155.93 - $173.01 $53.6 Million - $59.5 Million	343,706 Added 12.48%	3,097,742 $530 Million
Q3 2021 Nov 12, 2021	SELL	$161.5 - $179.47 $11.2 Million - $12.4 Million	-69,070 Reduced 2.45%	2,754,036 $445 Million
Q2 2021 Aug 13, 2021	BUY	$159.48 - $171.07 $178 Million - $190 Million	1,113,211 Added 65.1%	2,823,106 $465 Million
Q1 2021 May 14, 2021	BUY	$153.07 - $170.48 $36.8 Million - $40.9 Million	240,126 Added 16.34%	1,709,895 $281 Million
Q4 2020 Feb 12, 2021	BUY	$137.11 - $157.38 $110 Million - $127 Million	804,367 Added 120.88%	1,469,769 $231 Million
Q3 2020 Nov 13, 2020	BUY	$140.38 - $153.83 $93.4 Million - $102 Million	665,402 New	665,402 $99.1 Million
Q2 2020 Aug 12, 2020	SELL	$128.81 - $155.51 $1.06 Million - $1.28 Million	-8,215 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$111.14 - $153.99 $913,015 - $1.27 Million	8,215 New	8,215 $1.08 Million
Q4 2018 Feb 13, 2019	SELL	$122.84 - $147.84 $9.56 Million - $11.5 Million	-77,815 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$121.58 - $142.88 $3.91 Million - $4.59 Million	-32,135 Reduced 29.23%	77,815 $10.8 Million
Q2 2018 Aug 13, 2018	BUY	$119.4 - $131.76 $13.1 Million - $14.5 Million	109,950 New	109,950 $0

Others Institutions Holding JNJ

# of Institutions

4,139

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $404B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track Ray Dalio's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.

Account